81 FR 60012 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 169 (August 31, 2016)

Page Range		60012-60013
FR Document		2016-20996
Federal Register, Volume 81 Issue 169 (Wednesday, August 31, 2016)
[Federal Register Volume 81, Number 169 (Wednesday, August 31, 2016)]
[Notices]
[Pages 60012-60013]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-20996]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Cancer Prevention and Therapy.
    Date: September 21, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Syed M. Quadri, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 
20892, 301-435-1211, [email protected].

    Name of Committee: Oncology 1--Basic Translational Integrated 
Review Group; Cancer Etiology Study Section.
    Date: September 26-27, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Kinzie Hotel, 20 W. Kinzie St., Chicago, IL 60654.
    Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Dr., Room 4192, MSC 7806, Bethesda, MD 20892, 
301-451-4467, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR15-306: Lymphatics in Health and Disease in the Digestive 
System, Kidney and Urinary Tract.
    Date: September 28, 2016.
    Time: 1:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jianxin Hu, Ph.D., Scientific Review Officer, 
NINDS/NIH, Scientific Review Branch, 6001 Executive Blvd., Bethesda, 
MD 20892, [email protected].

    Name of Committee: Cell Biology Integrated Review Group; 
Development--2 Study Section.
    Date: September 29-30, 2016.
    Time: 8:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites DC, Convention Center, 900 10th Street 
NW., Washington, DC 20001.
    Contact Person: Rass M. Shayiq, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institute of Health, 
6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, (301) 
435-2359, [email protected].

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Neurotransporters, Receptors, 
and Calcium Signaling Study Section.
    Date: September 29-30, 2016.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Palomar Hotel, 2121 P Street NW., Washington, DC 20037.
    Contact Person: Peter B. Guthrie, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4182, MSC 7850, Bethesda, MD 
20892, (301) 435-1239, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Development and Application of PET and SPECT Imaging Ligands 
as Biomarkers for Drug Discovery and for Pathophysiological Studies 
of CNS Disorders (R21).
    Date: September 30, 2016
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Donald Scott Wright, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 
20892, (301) 435-8363, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Physical Activity and Weight Control Interventions Among 
Cancer Survivors: Effects on Biomarkers of Prognosis and Survival.
    Date: September 30, 2016.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Denise Wiesch, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3138, MSC 7770, Bethesda, MD 20892, (301) 437-
3478, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Pilot Clinical Urology Studies.
    Date: September 30, 2016.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ryan G. Morris, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 
20892, 301-435-1501, [email protected].

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Addiction Risks and Mechanisms Study 
Section.
    Date: October 3-4, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Westgate Hotel San Diego, 1055 Second Avenue, San 
Diego, CA 92101.
    Contact Person: Kristen Prentice, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD 
20892, (301) 496-0726, [email protected].

    Name of Committee: Cell Biology Integrated Review Group; Nuclear 
and Cytoplasmic Structure/Function and Dynamics Study Section.
    Date: October 3, 2016.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: David Balasundaram, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD 
20892, 301-435-1022, [email protected].

    Name of Committee: Surgical Sciences, Biomedical Imaging and 
Bioengineering Integrated Review Group; Bioengineering, Technology 
and Surgical Sciences Study Section.
    Date: October 3-4, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 60013]]

    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Khalid Masood, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5120, MSC 7854, Bethesda, MD 20892, 301-435-
2392, [email protected].

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Genomics, Computational Biology and Technology Study 
Section.
    Date: October 4-5, 2016.
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 
22102.
    Contact Person: Baishali Maskeri, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-827-2864, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 26, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-20996 Filed 8-30-16; 8:45 am]
BILLING CODE 4140-01-P
60012 Federal Register / Vol. 81, No. 169 / Wednesday, August 31, 2016 / Notices

Boulevard, Bethesda, MD 20892 (Telephone Place: Kinzie Hotel, 20 W. Kinzie St., Name of Committee: Center for Scientific
Conference Call). Chicago, IL 60654. Review Special Emphasis Panel; Physical
Contact Person: Elena Sanovich, Ph.D., Contact Person: Ola Mae Zack Howard, Activity and Weight Control Interventions
Scientific Review Officer, Review Branch, Ph.D., Scientific Review Officer, Center for Among Cancer Survivors: Effects on
DEA, NIDDK, National Institutes of Health, Scientific Review, National Institutes of Biomarkers of Prognosis and Survival.
Room 7351, 6707 Democracy Boulevard, Health, 6701 Rockledge Dr., Room 4192, MSC Date: September 30, 2016.
Bethesda, MD 20892–2542, (301) 594–8886, 7806, Bethesda, MD 20892, 301–451–4467, Time: 2:00 p.m. to 5:00 p.m.
sanoviche@mail.nih.gov. howardz@mail.nih.gov. Agenda: To review and evaluate grant
(Catalogue of Federal Domestic Assistance Name of Committee: Center for Scientific applications.
Program Nos. 93.847, Diabetes, Review Special Emphasis Panel; PAR15–306: Place: National Institutes of Health, 6701
Endocrinology and Metabolic Research; Lymphatics in Health and Disease in the Rockledge Drive, Bethesda, MD 20892
93.848, Digestive Diseases and Nutrition Digestive System, Kidney and Urinary Tract. (Virtual Meeting).
Research; 93.849, Kidney, Diseases, Urology Date: September 28, 2016. Contact Person: Denise Wiesch, Ph.D.,
and Hematology Research, National Institutes Time: 1:00 p.m. to 2:30 p.m. Scientific Review Officer, Center for
of Health, HHS) Agenda: To review and evaluate grant Scientific Review, National Institutes of
applications. Health, 6701 Rockledge Drive, Room 3138,
Dated: August 25, 2016. Place: National Institutes of Health, 6701 MSC 7770, Bethesda, MD 20892, (301) 437–
Rockledge Drive, Bethesda, MD 20892 3478, wieschd@csr.nih.gov.
David Clary,
(Telephone Conference Call). Name of Committee: Center for Scientific
Program Analyst, Office of Federal Advisory
Contact Person: Jianxin Hu, Ph.D., Review Special Emphasis Panel; Pilot
Committee Policy.
Scientific Review Officer, NINDS/NIH, Clinical Urology Studies.
[FR Doc. 2016–21000 Filed 8–30–16; 8:45 am] Scientific Review Branch, 6001 Executive Date: September 30, 2016.
BILLING CODE 4140–01–P Blvd., Bethesda, MD 20892, jianxinh@ Time: 2:00 p.m. to 4:00 p.m.
mail.nih.gov. Agenda: To review and evaluate grant
Name of Committee: Cell Biology applications.
DEPARTMENT OF HEALTH AND Integrated Review Group; Development—2 Place: National Institutes of Health, 6701
HUMAN SERVICES Study Section. Rockledge Drive, Bethesda, MD 20892
Date: September 29–30, 2016. (Telephone Conference Call).
National Institutes of Health Time: 8:00 a.m. to 12:30 p.m. Contact Person: Ryan G. Morris, Ph.D.,
Agenda: To review and evaluate grant Scientific Review Officer, Center for
Center for Scientific Review; Notice of applications. Scientific Review, National Institutes of
Closed Meetings Place: Embassy Suites DC, Convention Health, 6701 Rockledge Drive, Room 4205,
Center, 900 10th Street NW., Washington, DC MSC 7814, Bethesda, MD 20892, 301–435–
Pursuant to section 10(d) of the 20001. 1501, morrisr@csr.nih.gov.
Federal Advisory Committee Act, as Contact Person: Rass M. Shayiq, Ph.D., Name of Committee: Risk, Prevention and
amended (5 U.S.C. App.), notice is Scientific Review Officer, Center for Health Behavior Integrated Review Group;
hereby given of the following meetings. Scientific Review, National Institute of Addiction Risks and Mechanisms Study
Health, 6701 Rockledge Drive, Room 2182, Section.
The meetings will be closed to the
MSC 7818, Bethesda, MD 20892, (301) 435– Date: October 3–4, 2016.
public in accordance with the 2359, shayiqr@csr.nih.gov. Time: 8:00 a.m. to 5:00 p.m.
provisions set forth in sections Agenda: To review and evaluate grant
Name of Committee: Molecular, Cellular
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., and Developmental Neuroscience Integrated applications.
as amended. The grant applications and Review Group; Neurotransporters, Receptors, Place: The Westgate Hotel San Diego, 1055
the discussions could disclose and Calcium Signaling Study Section. Second Avenue, San Diego, CA 92101.
confidential trade secrets or commercial Date: September 29–30, 2016. Contact Person: Kristen Prentice, Ph.D.,
property such as patentable material, Time: 8:00 a.m. to 12:00 p.m. Scientific Review Officer, Center for
and personal information concerning Agenda: To review and evaluate grant Scientific Review, National Institutes of
applications. Health, 6701 Rockledge Drive, Room 3112,
individuals associated with the grant
Place: Palomar Hotel, 2121 P Street NW., MSC 7808, Bethesda, MD 20892, (301) 496–
applications, the disclosure of which 0726, prenticekj@mail.nih.gov.
Washington, DC 20037.
would constitute a clearly unwarranted
Contact Person: Peter B. Guthrie, Ph.D., Name of Committee: Cell Biology
invasion of personal privacy. Scientific Review Officer, Center for Integrated Review Group; Nuclear and
Name of Committee: Center for Scientific Scientific Review, National Institutes of Cytoplasmic Structure/Function and
Review Special Emphasis Panel; Member Health, 6701 Rockledge Drive, Room 4182, Dynamics Study Section.
Conflict: Cancer Prevention and Therapy. MSC 7850, Bethesda, MD 20892, (301) 435– Date: October 3, 2016.
Date: September 21, 2016. 1239, guthriep@csr.nih.gov. Time: 8:00 a.m. to 8:00 p.m.
Time: 12:00 p.m. to 2:00 p.m. Name of Committee: Center for Scientific Agenda: To review and evaluate grant
Agenda: To review and evaluate grant Review Special Emphasis Panel; applications.
applications. Development and Application of PET and Place: Residence Inn Bethesda, 7335
Place: National Institutes of Health, 6701 SPECT Imaging Ligands as Biomarkers for Wisconsin Avenue, Bethesda, MD 20814.
Rockledge Drive, Bethesda, MD 20892 Drug Discovery and for Pathophysiological Contact Person: David Balasundaram,
(Telephone Conference Call). Studies of CNS Disorders (R21). Ph.D., Scientific Review Officer, Center for
Contact Person: Syed M. Quadri, Ph.D., Date: September 30, 2016 Scientific Review, National Institutes of
Scientific Review Officer, Center for Time: 1:00 p.m. to 3:00 p.m. Health, 6701 Rockledge Drive, Room 5189,
Scientific Review, National Institutes of Agenda: To review and evaluate grant MSC 7840, Bethesda, MD 20892, 301–435–
Health, 6701 Rockledge Drive, Room 6210, applications. 1022, balasundaramd@csr.nih.gov.
MSC 7804, Bethesda, MD 20892, 301–435– Place: Ritz-Carlton Hotel at Pentagon City, Name of Committee: Surgical Sciences,
mstockstill on DSK3G9T082PROD with NOTICES

1211, quadris@csr.nih.gov. 1250 South Hayes Street, Arlington, VA Biomedical Imaging and Bioengineering
Name of Committee: Oncology 1—Basic 22202. Integrated Review Group; Bioengineering,
Translational Integrated Review Group; Contact Person: Donald Scott Wright, Technology and Surgical Sciences Study
Cancer Etiology Study Section. Ph.D., Scientific Review Officer, Center for Section.
Date: September 26–27, 2016. Scientific Review, National Institutes of Date: October 3–4, 2016.
Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 5108, Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant MSC 7854, Bethesda, MD 20892, (301) 435– Agenda: To review and evaluate grant
applications. 8363, wrightds@csr.nih.gov. applications.

VerDate Sep<11>2014 21:59 Aug 30, 2016 Jkt 238001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\31AUN1.SGM 31AUN1
Federal Register / Vol. 81, No. 169 / Wednesday, August 31, 2016 / Notices 60013

Place: Bethesda North Marriott Hotel & 2008 (73 FR 75122); and on April 30, HHS-Certified Laboratories
Conference Center, 5701 Marinelli Road, 2010 (75 FR 22809).
Bethesda, MD 20852. ACM Medical Laboratory, Inc., 160
A notice listing all currently HHS-
Contact Person: Khalid Masood, Ph.D., Elmgrove Park, Rochester, NY 14624,
certified laboratories and IITFs is
Scientific Review Officer, Center for 585–429–2264
published in the Federal Register
Scientific Review, National Institutes of Aegis Analytical Laboratories, Inc., 345
during the first week of each month. If
Health, 6701 Rockledge Drive, Room 5120, Hill Ave., Nashville, TN 37210, 615–
MSC 7854, Bethesda, MD 20892, 301–435– any laboratory or IITF certification is
255–2400 (Formerly: Aegis Sciences
2392, masoodk@csr.nih.gov. suspended or revoked, the laboratory or
Corporation, Aegis Analytical
Name of Committee: Genes, Genomes, and IITF will be omitted from subsequent
Laboratories, Inc., Aegis Analytical
Genetics Integrated Review Group; lists until such time as it is restored to
Laboratories)
Genomics, Computational Biology and full certification under the Mandatory
Alere Toxicology Services, 1111 Newton
Technology Study Section. Guidelines.
If any laboratory or IITF has St., Gretna, LA 70053, 504–361–8989/
Date: October 4–5, 2016.
Time: 8:30 a.m. to 6:00 p.m. withdrawn from the HHS National 800–433–3823 (Formerly: Kroll
Agenda: To review and evaluate grant Laboratory Certification Program (NLCP) Laboratory Specialists, Inc.,
applications. during the past month, it will be listed Laboratory Specialists, Inc.)
Place: Ritz-Carlton Hotel, 1700 Tysons at the end and will be omitted from the Alere Toxicology Services, 450
Boulevard, McLean, VA 22102. monthly listing thereafter. Southlake Blvd., Richmond, VA
Contact Person: Baishali Maskeri, Ph.D., 23236, 804–378–9130 (Formerly:
This notice is also available on the
Scientific Review Officer, Center for Kroll Laboratory Specialists, Inc.,
Scientific Review, National Institutes of
Internet at http://www.samhsa.gov/
workplace. Scientific Testing Laboratories, Inc.;
Health, 6701 Rockledge Drive, Bethesda, MD
Kroll Scientific Testing Laboratories,
20892, 301–827–2864, maskerib@ FOR FURTHER INFORMATION CONTACT:
mail.nih.gov. Inc.)
Giselle Hersh, Division of Workplace Baptist Medical Center-Toxicology
(Catalogue of Federal Domestic Assistance Programs, SAMHSA/CSAP, 5600
Program Nos. 93.306, Comparative Medicine;
Laboratory, 11401 I–30, Little Rock,
Fishers Lane, Room 16N03A, Rockville, AR 72209–7056, 501–202–2783
93.333, Clinical Research, 93.306, 93.333, Maryland 20857; 240–276–2600 (voice).
93.337, 93.393–93.396, 93.837–93.844, (Formerly: Forensic Toxicology
SUPPLEMENTARY INFORMATION: The Laboratory Baptist Medical Center)
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS) Mandatory Guidelines were initially Clinical Reference Laboratory, Inc., 8433
developed in accordance with Executive Quivira Road, Lenexa, KS 66215–
Dated: August 26, 2016. Order 12564 and section 503 of Public
Anna Snouffer,
2802, 800–445–6917
Law 100–71. The ‘‘Mandatory DrugScan, Inc., 200 Precision Road,
Deputy Director, Office of Federal Advisory Guidelines for Federal Workplace Drug
Committee Policy.
Suite 200, Horsham, PA 19044, 800–
Testing Programs,’’ as amended in the 235–4890
[FR Doc. 2016–20996 Filed 8–30–16; 8:45 am] revisions listed above, requires strict Dynacare*, 245 Pall Mall Street,
BILLING CODE 4140–01–P standards that laboratories and IITFs London, ONT, Canada N6A 1P4, 519–
must meet in order to conduct drug and 679–1630 (Formerly: Gamma-
specimen validity tests on urine Dynacare Medical Laboratories)
DEPARTMENT OF HEALTH AND specimens for federal agencies. ElSohly Laboratories, Inc., 5 Industrial
HUMAN SERVICES To become certified, an applicant Park Drive, Oxford, MS 38655, 662–
laboratory or IITF must undergo three
Substance Abuse and Mental Health 236–2609
rounds of performance testing plus an
Services Administration Fortes Laboratories, Inc., 25749 SW
on-site inspection. To maintain that
Canyon Creek Road, Suite 600,
certification, a laboratory or IITF must
Current List of HHS-Certified Wilsonville, OR 97070, 503–486–1023
participate in a quarterly performance
Laboratories and Instrumented Initial Laboratory Corporation of America
testing program plus undergo periodic,
Testing Facilities Which Meet Minimum Holdings, 7207 N. Gessner Road,
on-site inspections.
Standards To Engage in Urine Drug Laboratories and IITFs in the Houston, TX 77040, 713–856–8288/
Testing for Federal Agencies applicant stage of certification are not to 800–800–2387
be considered as meeting the minimum Laboratory Corporation of America
AGENCY: Substance Abuse and Mental Holdings, 69 First Ave., Raritan, NJ
Health Services Administration, HHS. requirements described in the HHS
Mandatory Guidelines. A HHS-certified 08869, 908–526–2400/800–437–4986
ACTION: Notice. laboratory or IITF must have its letter of (Formerly: Roche Biomedical
certification from HHS/SAMHSA Laboratories, Inc.)
SUMMARY: The Department of Health and (formerly: HHS/NIDA), which attests Laboratory Corporation of America
Human Services (HHS) notifies federal that it has met minimum standards. Holdings, 1904 Alexander Drive,
agencies of the laboratories and In accordance with the Mandatory Research Triangle Park, NC 27709,
Instrumented Initial Testing Facilities Guidelines dated November 25, 2008 919–572–6900/800–833–3984
(IITF) currently certified to meet the (73 FR 71858), the following HHS- (Formerly: LabCorp Occupational
standards of the Mandatory Guidelines certified laboratories and IITFs meet the Testing Services, Inc., CompuChem
for Federal Workplace Drug Testing minimum standards to conduct drug Laboratories, Inc.; CompuChem
Programs (Mandatory Guidelines). The and specimen validity tests on urine Laboratories, Inc., A Subsidiary of
Mandatory Guidelines were first Roche Biomedical Laboratory; Roche
mstockstill on DSK3G9T082PROD with NOTICES

specimens:
published in the Federal Register on CompuChem Laboratories, Inc., A
April 11, 1988 (53 FR 11970), and HHS-Certified Instrumented Initial Member of the Roche Group)
subsequently revised in the Federal Testing Facilities Laboratory Corporation of America
Register on June 9, 1994 (59 FR 29908); Dynacare, 6628 50th Street NW., Holdings, 1120 Main Street,
September 30, 1997 (62 FR 51118); Edmonton, AB Canada T6B 2N7, 780– Southaven, MS 38671, 866–827–8042/
April 13, 2004 (69 FR 19644); November 784–1190 (Formerly: Gamma- 800–233–6339 (Formerly: LabCorp
25, 2008 (73 FR 71858); December 10, Dynacare Medical Laboratories) Occupational Testing Services, Inc.;

VerDate Sep<11>2014 21:59 Aug 30, 2016 Jkt 238001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\31AUN1.SGM 31AUN1
Document Created: 2018-02-02 12:15:27
Document Modified: 2018-02-02 12:15:27
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 21, 2016.
FR Citation		81 FR 60012
81 FR 60012 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 169 (August 31, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
